Faron Pharmaceuticals Appoints Two Non-Executive Directors
19 April 2017 - 5:31PM
Dow Jones News
LONDON--Finnish drug group Faron Pharmaceuticals Ltd (FARN.LN)
Wednesday said it has appointed two new non-executive
directors.
Gregory Brown has more than 35 years of experience in healthcare
and investment, having most recently founded HealthCare Royalty
Partners, a health-focused private asset manager investing in
bio-pharmaceutical and medical products, where he is
Vice-Chairman.
John Poulos has spent 38 years working for drug groups AbbVie
Inc (ABBV) and Abbott Pharmaceuticals.
-Write to Philip Waller at philip.waller@wsj.com
(END) Dow Jones Newswires
April 19, 2017 03:16 ET (07:16 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
Faron Pharmaceuticals Oy (LSE:FARN)
Historical Stock Chart
From Apr 2024 to May 2024
Faron Pharmaceuticals Oy (LSE:FARN)
Historical Stock Chart
From May 2023 to May 2024